| Year |
Citation |
Score |
| 2024 |
Serrano D, Cella D, Husereau D, King-Kallimanis B, Mendoza T, Salmonson T, Stone A, Zaleta A, Dhanda D, Moshyk A, Liu F, Shields AL, Taylor F, Spite S, Shaw JW, et al. Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance: a position statement on a modular approach. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 38265747 DOI: 10.1007/s11136-023-03587-8 |
0.302 |
|
| 2019 |
Mesa RA, Su Y, Woolfson A, Prchal JT, Turnbull K, Jabbour E, Scherber R, Shields AL, Krohe M, Ojo F, Pompilus F, Cappelleri JC, Harrison C. Development of a symptom assessment in patients with myelofibrosis: qualitative study findings. Health and Quality of Life Outcomes. 17: 61. PMID 30975150 DOI: 10.1186/S12955-019-1121-1 |
0.385 |
|
| 2019 |
Hirano I, Dellon ES, Murray J, Peterson KA, Banderas B, Woolley JM, Ollis S, Foley C, Love E, Shields A, Shaw C, Rasmussen HS. 1247 Development of a Patient Reported Outcome (PRO) Questionnaire to Assess the Symptoms of Eosinophilic Gastritis and Gastroenteritis (EG/EGE-SQ©) The American Journal of Gastroenterology. 114. DOI: 10.14309/01.Ajg.0000594516.37251.84 |
0.386 |
|
| 2019 |
Banderas B, Lizzul P, Ahluwalia G, Liu C, Kinchev P, Stroehmann D, Li S, Galipeau N, Mossman B, McDonald J, Shields A. Psy51 Psychometric Performance Of Plaque Psoriasis Patient Reported Outcome Numeric Rating Scales In A Phase 2B Clinical Trial Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2678 |
0.314 |
|
| 2019 |
Taylor F, Shields A, Li S, Yip C, Padilla B, Green T, Radia D, Deininger M, Gotlib JR, Bose P, Drummond MW, Hexner E, Robinson W, Quiery A, Winton EF, et al. Pro143 Psychometric Evaluation Of The Advanced Systemic Mastocytosis Symptom Assessment Form (Advsm-Saf) In Patients With Advanced Systemic Mastocytosis Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2472 |
0.327 |
|
| 2019 |
Shields A, Taylor F, Lamoureux R, Padilla B, Severson K, Green T, Mar B. Pro142 Psychometric Performance Of The Indolent Systemic Mastocytosis Symptom Assessment Form (Ism-Saf) Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.2471 |
0.32 |
|
| 2018 |
Turner-Bowker DM, Lamoureux RE, Stokes J, Litcher-Kelly L, Galipeau N, Yaworsky A, Solomon J, Shields AL. Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 839-842. PMID 30005756 DOI: 10.1016/J.Jval.2017.11.014 |
0.359 |
|
| 2018 |
Yu-Isenberg K, Gray GD, Foley C, Stokes JT, Shields A, Dickie G, Lamoureux R, Jackson CV, Padilla B, Polonsky W. Exploring the Type 2 Diabetes Mellitus Experience from the Patient Perspective Diabetes. 67. DOI: 10.2337/Db18-725-P |
0.325 |
|
| 2018 |
Dickie G, Mazar I, Espensen A, Lamoureux R, Severson K, Padilla B, Shields A. Pmu118 - Cognitive Debriefing Interview Studies To Inform Patient-Reported Outcome Questionnaire Development: A Literature Review And Suggested Reporting Guidelines Value in Health. 21. DOI: 10.1016/J.Jval.2018.09.1954 |
0.316 |
|
| 2017 |
Taylor F, Higgins S, Carson RT, Eremenco S, Foley C, Lacy BE, Parkman HP, Reasner DS, Shields AL, Tack J, Talley NJ. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD). The American Journal of Gastroenterology. PMID 28925989 DOI: 10.1038/Ajg.2017.265 |
0.342 |
|
| 2017 |
Banderas B, Skup M, Shields AL, Stokes J, Foley C, Ganguli A. Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational study. Current Medical Research and Opinion. 1-31. PMID 28885061 DOI: 10.1080/03007995.2017.1378173 |
0.342 |
|
| 2017 |
Kimball AB, Sundaram M, Banderas B, Foley C, Shields AL. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa. The Journal of Dermatological Treatment. 1-40. PMID 28608738 DOI: 10.1080/09546634.2017.1341614 |
0.39 |
|
| 2017 |
Banderas B, Skup M, Shields AL, Mazar I, Ganguli A. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. Current Medical Research and Opinion. 1-27. PMID 28574727 DOI: 10.1080/03007995.2017.1338562 |
0.334 |
|
| 2017 |
Armstrong AW, Banderas B, Foley C, Stokes J, Sundaram M, Shields AL. Development and Psychometric Evaluation of the Self-Assessment of Psoriasis Symptoms (SAPS) - Clinical Trial and the SAPS - Real World Patient-Reported Outcomes. The Journal of Dermatological Treatment. 1-41. PMID 28147886 DOI: 10.1080/09546634.2017.1290206 |
0.342 |
|
| 2017 |
Mazar I, Stokes J, Foley C, Galipeau N, Shields A. Qualitative Research Methods For Collecting, Analyzing, And Presenting Patient-Reported Data On Noticeable And Important Change In Disease-Related Signs And Symptoms Value in Health. 20. DOI: 10.1016/J.Jval.2017.08.2172 |
0.306 |
|
| 2016 |
Turner-Bowker DM, Hao Y, Foley C, Galipeau N, Mazar I, Krohe M, Globe D, Shields AL. The Use of Patient-Reported Outcomes in Advanced Breast Cancer Clinical Trials: A Review of the Published Literature. Current Medical Research and Opinion. 1-37. PMID 27331272 DOI: 10.1080/03007995.2016.1205005 |
0.332 |
|
| 2016 |
Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments. The Patient. PMID 27020447 DOI: 10.1007/S40271-016-0164-1 |
0.389 |
|
| 2016 |
Su Y, Woolfson A, Prchal JT, Turnbull KW, Harrison CN, Jabbour E, Scherber RM, Shields A, Krohe M, Ojo F, Pompilus F, Mesa RA. Symptom assessment in patients with JAK inhibitor naïve and JAK inhibitor failed myelofibrosis. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E18559 |
0.351 |
|
| 2016 |
Mazar, Evans E, Taylor F, Patki A, Ojo O, Lamoureux R, Horny H, Reiter A, Gotlib J, Shields A. Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF) Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.224 |
0.346 |
|
| 2016 |
Spalding J, Hudgens S, Litcher-Kelly L, Shields A, Kitt T, Ojo O, Kristy R, Lee E, Mathias A, Morrissey L, Houle C. Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in Echocardiography Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.070 |
0.317 |
|
| 2016 |
Jacobson T, Edelman S, Davidson M, Galipeau N, Shields A, Mallya U, Koren A. Development and Content Validation of a Patient-Reported Outcome Measure to Evaluate Statin Intolerance in the Real World Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.173 |
0.353 |
|
| 2015 |
Shields A, Coon C, Hao Y, Krohe M, Yaworsky A, Mazar I, Foley C, Globe D. Patient-reported outcomes for US oncology labeling: review and discussion of score interpretation and analysis methods. Expert Review of Pharmacoeconomics & Outcomes Research. 1-9. PMID 26594897 DOI: 10.1586/14737167.2015.1115348 |
0.415 |
|
| 2015 |
Kimball A, Sundaram M, Mathias A, Foley C, Shields A. Measuring Disease specific impact and symptoms among patients with Hidradenitis Suppurativa Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.1061 |
0.319 |
|
| 2014 |
Pleil A, Mathias A, Galipeau N, Shields A, Jensen J. The Reliability Of The Patient-Reported Scar Evaluation Questionnaire (Pr-Seq) In A Cohort Of Adults With Linear Scars Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.1677 |
0.349 |
|
| 2013 |
Stokes J, Evans CJ, Pompilus F, Shields AL, Summers KH. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials. The Patient. 6: 291-305. PMID 24062234 DOI: 10.1007/S40271-013-0026-Z |
0.341 |
|
| 2013 |
Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M. Item-level psychometric properties for a new patient-reported psoriasis symptom diary. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 1014-22. PMID 24041351 DOI: 10.1016/J.Jval.2013.07.002 |
0.381 |
|
| 2013 |
Connery H, Greenfield S, Livchits V, McGrady L, Patrick N, Lastimoso CS, Heney JH, Nelson AK, Shields A, Stepanova YP, Petrova LY, Anastasov OV, Novoseltseva OI, Shin SS. Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial. Substance Use & Misuse. 48: 784-92. PMID 23750742 DOI: 10.3109/10826084.2013.793715 |
0.326 |
|
| 2013 |
Mesa RA, Shields A, Hare T, Erickson-Viitanen S, Sun W, Sarlis NJ, Sandor V, Levy RS, Verstovsek S. Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study. Leukemia Research. 37: 911-6. PMID 23684482 DOI: 10.1016/J.Leukres.2013.04.017 |
0.416 |
|
| 2013 |
Mesa RA, Gotlib J, Gupta V, Catalano JV, Deininger MW, Shields AL, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH, Hare T, Erickson-Viitanen S, Sun W, Sandor V, et al. Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1285-92. PMID 23423753 DOI: 10.1200/Jco.2012.44.4489 |
0.401 |
|
| 2013 |
Trask PC, Taylor F, Shields A, Gallagher M, Mehta J, Foley C, Olude F, Lamoureux R, Iovin R, Hsu K. Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM Blood. 122: 2989-2989. DOI: 10.1182/Blood.V122.21.2989.2989 |
0.352 |
|
| 2013 |
Pleil A, Jensen J, Galipeau N, Shields A. Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.183 |
0.332 |
|
| 2012 |
Pleil A, Jensen J, Galipeau N, Olude O, Klemm M, Shields A. PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ) Value in Health. 15. DOI: 10.1016/J.Jval.2012.08.2074 |
0.303 |
|
| 2012 |
Mesa R, Shields A, Hare T, Erickson-Viitanen S, Sun W, Verstovsek S. PCN109 Progressive Worsening of Patient-Reported Outcomes in Untreated Patients With Myelofibrosis Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.1226 |
0.309 |
|
| 2011 |
Mesa RA, Gotlib J, Gupta V, DiPersio JF, Catalano J, Deininger MW, Shields A, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH, Hare T, Erickson-Viitanen S, Sun W, et al. Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF, Blood. 118: 3842-3842. DOI: 10.1182/Blood.V118.21.3842.3842 |
0.367 |
|
| 2010 |
Mathew T, Shields A, Yanov S, Golubchikova V, Strelis A, Yanova G, Mishustin S, Fitzmaurice G, Connery H, Shin S, Greenfield SF. Performance of the alcohol use disorders identification test among tuberculosis patients in Russia. Substance Use & Misuse. 45: 598-612. PMID 20141466 DOI: 10.3109/10826080903464194 |
0.386 |
|
| 2010 |
Greenfield SF, Shields A, Connery HS, Livchits V, Yanov SA, Lastimoso CS, Strelis AK, Mishustin SP, Fitzmaurice G, Mathew TA, Shin S. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcoholism, Clinical and Experimental Research. 34: 317-30. PMID 19930235 DOI: 10.1111/J.1530-0277.2009.01094.X |
0.316 |
|
| 2009 |
Mathew TA, Shields AL, Imasheva A, Shin SS, Mishustin SP, Peremitin GG, Strelis AK, Yanova GV, Greenfield SF, Furin JJ. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia. Culture, Medicine and Psychiatry. 33: 523-37. PMID 19768525 DOI: 10.1007/S11013-009-9148-0 |
0.319 |
|
| 2009 |
Miller CS, Woodson J, Howell RT, Shields AL. Assessing the reliability of scores produced by the substance abuse subtle screening inventory. Substance Use & Misuse. 44: 1090-100. PMID 19544146 DOI: 10.1080/10826080802486772 |
0.384 |
|
| 2009 |
Mathew TA, Yanov SA, Mazitov R, Mishustin SP, Strelis AK, Yanova GV, Golubchikova VT, Taran DV, Golubkov A, Shields AL, Greenfield SF, Shin SS. Integration of alcohol use disorders identification and management in the tuberculosis programme in Tomsk Oblast, Russia. European Journal of Public Health. 19: 16-8. PMID 19112073 DOI: 10.1093/Eurpub/Ckn093 |
0.36 |
|
| 2008 |
Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: 322-33. PMID 18380645 DOI: 10.1111/J.1524-4733.2007.00231.X |
0.327 |
|
| 2008 |
Howell RT, Shields AL. The file drawer problem in reliability generalization: A strategy to compute a fail-safe N with reliability coefficients Educational and Psychological Measurement. 68: 120-128. DOI: 10.1177/0013164407301528 |
0.334 |
|
| 2008 |
Shields AL, Campfield DC, Miller CS, Howell RT, Wallace K, Weiss RD. Score reliability of adolescent alcohol screening measures: A meta-analytic inquiry Journal of Child and Adolescent Substance Abuse. 17: 75-97. DOI: 10.1080/15470650802292855 |
0.406 |
|
| 2007 |
Shields AL, Howell RT, Potter JS, Weiss RD. The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Substance Use & Misuse. 42: 1783-800. PMID 17934995 DOI: 10.1080/10826080701212295 |
0.41 |
|
| 2007 |
Miller CS, Shields AL, Campfield D, Wallace KA, Weiss RD. Substance use scales of the Minnesota multiphasic personality inventory: An exploration of score reliability via meta-analysis Educational and Psychological Measurement. 67: 1052-1065. DOI: 10.1177/0013164406299130 |
0.435 |
|
| 2005 |
Shields AL, Hufford MR. Assessing motivation to change among problem drinkers with and without co-occurring major depression. Journal of Psychoactive Drugs. 37: 401-8. PMID 16480167 DOI: 10.1080/02791072.2005.10399813 |
0.327 |
|
| 2005 |
Ryngala DJ, Shields AL, Caruso JC. Reliability generalization of the revised children's manifest anxiety scale Educational and Psychological Measurement. 65: 259-271. DOI: 10.1177/0013164404272495 |
0.671 |
|
| 2004 |
Shields AL, Guttmannova K, Caruso JC. An examination of the factor structure of the Alcohol Use Disorders Identification Test in two high-risk samples. Substance Use & Misuse. 39: 1161-82. PMID 15387208 DOI: 10.1081/Ja-120038034 |
0.67 |
|
| 2004 |
Shields AL, Caruso JC. A Reliability Induction and Reliability Generalization Study of the Cage Questionnaire Educational and Psychological Measurement. 64: 254-270. DOI: 10.1177/0013164403261814 |
0.677 |
|
| 2003 |
Hufford MR, Witkiewitz K, Shields AL, Kodya S, Caruso JC. Relapse as a nonlinear dynamic system: application to patients with alcohol use disorders. Journal of Abnormal Psychology. 112: 219-27. PMID 12784831 DOI: 10.1037/0021-843X.112.2.219 |
0.644 |
|
| 2003 |
Shields AL, Caruso JC. Reliability generalization of the alcohol use disorders identification test Educational and Psychological Measurement. 63: 404-413. DOI: 10.1177/0013164403063003004 |
0.689 |
|
| 2002 |
Hufford MR, Shields AL, Shiffman S, Paty J, Balabanis M. Reactivity to ecological momentary assessment: an example using undergraduate problem drinkers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 16: 205-11. PMID 12236455 DOI: 10.1037/0893-164X.16.3.205 |
0.32 |
|
| Show low-probability matches. |